Its more of a red-carpet experience with us, Belle Medical president Wendy Edmunds said
[53] The mechanism of action for Rimonabant was cannabinoid receptor CB1 antagonism, in other words, blocking the cannabinoid receptor (the one that weed, for example, binds to and activates in order to make you all happy)
The exact mechanism isnt fully understood, but researchers believe the drug affects blood flow to the optic nerve, particularly in patients with existing cardiovascular risk factors
No drastic measures, no injections just nature doing what it was designed to do
The product information available through the EMA states that the visceral abnormalities and major skeletal malformations seen after maternal exposure to semaglutide are probably due to embryotoxicity caused by a GLP-1 receptor-mediated impairment of the nutrient supply across the rat yolk sac, which has unclear translational significance for humans due to a difference in yolk sac anatomy